Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00661_DB06695_nanopub.RA7zF5ClL7j8aIFICWHicxF8mRCWX9Fxu3D7g-p811ay8#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00661_DB06695 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00661_DB06695 label "DDI between Verapamil and Dabigatran etexilate - Verapamil may increase serum concentrations of the active metabolite(s) of dabigatran etexilate, resulting in an increased risk of bleeding. It is also a strong p-glycoprotein inhibitor. Therapy modification should be considered. [drugbank_resource:DB00661_DB06695]" assertion.
- drugbank_resource:DB00661_DB06695 identifier "drugbank_resource:DB00661_DB06695" assertion.
- drugbank_resource:DB00661_DB06695 title "DDI between Verapamil and Dabigatran etexilate - Verapamil may increase serum concentrations of the active metabolite(s) of dabigatran etexilate, resulting in an increased risk of bleeding. It is also a strong p-glycoprotein inhibitor. Therapy modification should be considered." assertion.
- drugbank:DB00661 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00661_DB06695 assertion.
- drugbank:DB06695 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00661_DB06695 assertion.